Sonic Healthcare Ltd ADR SKHHY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $15.82
- Day Range
- $15.86–15.88
- 52-Week Range
- $12.94–19.25
- Bid/Ask
- $15.76 / $15.98
- Shares Outstanding
- 494.24M
- Market Cap
- $7.85B
- Volume/Avg
- 73,889 / 115,508
Key Statistics
- Price/Earnings (Normalized)
- 20.49
- Price/Sales
- 1.15
- Dividend Yield (Trailing)
- 4.62%
- Dividend Yield (Forward)
- 4.62%
- Total Yield
- 4.63%
Company Profile
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 41,000
- Website
- https://www.sonichealthcare.com
Competitors
Valuation
|
Metric
|
SKHHY
|
DGX
|
LH
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.49 | 22.33 | 18.37 |
Price/Book Value | 1.36 | 3.47 | 3.02 |
Price/Sales | 1.15 | 2.31 | 1.86 |
Price/Cash Flow | 8.82 | 13.78 | 11.47 |
Price/Earnings
SKHHY
DGX
LH
Financial Strength
|
Metric
|
SKHHY
|
DGX
|
LH
|
|---|---|---|---|
Quick Ratio | 0.84 | 1.28 | 1.25 |
Current Ratio | 1.01 | 1.59 | 1.80 |
Interest Coverage | 4.83 | 6.17 | 6.43 |
Quick Ratio
SKHHY
DGX
LH
Profitability
|
Metric
|
SKHHY
|
DGX
|
LH
|
|---|---|---|---|
Return on Assets (Normalized) | 3.50% | 7.32% | 6.57% |
Return on Equity (Normalized) | 6.77% | 16.42% | 14.08% |
Return on Invested Capital (Normalized) | 5.02% | 10.01% | 9.11% |
Return on Assets
SKHHY
DGX
LH
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|VDvQzjv | LOCK|ls | $222B | |||
| Danaher Corp
DHR
| LOCK|%^<??s> | LOCK|?# | $147B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|P#NRHx^ | LOCK|P@ | $47B | |||
| Agilent Technologies Inc
A
| LOCK|R%%?#G@ | LOCK|?&l | $42B | |||
| Waters Corp
WAT
| LOCK|J@^s^Wn | LOCK|G> | $40B | |||
| IQVIA Holdings Inc
IQV
| LOCK|&#&?kD | LOCK|vL<g | $40B | |||
| Illumina Inc
ILMN
| LOCK|<HJrh<S | LOCK|<H!S | $29B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|^^%Q!zbp | LOCK|%m@D | $29B | |||
| Quest Diagnostics Inc
DGX
| LOCK|^Cnj^G | LOCK|G&l# | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|bctr%NJ | LOCK|dT%@H | $26B |
United States